#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA682932	B	In vitro inhibition of [3H]FPP incorporation into H-Ras-CVLS by Farnesyl transferase	Homo sapiens	11	ALA1132630	protein complex format	Scientific Literature
2.	ALA682705	B	Inhibitory concentration against farnesyltransferase was determined	Homo sapiens	17	ALA1149326	protein complex format	Scientific Literature
3.	ALA739454	F	In vivo for inhibition of farnesylation based on the inhibition of H-Ras processing.		18	ALA1132630	organism-based format	Scientific Literature
4.	ALA739456	F	In vivo inhibition of geranylgeranylation based on the inhibition of Rap1A processing.	Mus musculus	18	ALA1132630	organism-based format	Scientific Literature
5.	ALA770239	B	In vitro inhibition of [3H]GGPP incorporation into H-Ras-CVLL by Geranylgeranyl transferase type I	Homo sapiens	11	ALA1132630	protein complex format	Scientific Literature
6.	ALA850690	F	Relative selectivity for H-Ras farnesylation and Rap1A geranylgeranylation as ratio of IC50s	Mus musculus	8	ALA1132630	assay format	Scientific Literature
7.	ALA850692	B	Relative selectivity farnesyl (Ha-ras-CVLS) and geranylgeranyl (Ha-ras-CVLL) transferases as ratio of IC50s	Homo sapiens	11	ALA1132630	protein complex format	Scientific Literature
8.	ALA4185520	B	Inhibition of FTase isolated from human Burkitt's lymphoma cells assessed as decrease in transfer of [3H]farnesyl from [3H]farnesyl PPi to H-Ras-CVLS	Homo sapiens	4	ALA4184146	assay format	Scientific Literature
9.	ALA4185533	B	Inhibition of GGTase1 isolated from human Burkitt's lymphoma cells assessed as decrease in transfer of [3H]H]geranylgeranyl from [3H]geranylgeranyl PPi to H-Ras-CVLL	Homo sapiens	1	ALA4184146	assay format	Scientific Literature
10.	ALA4421915	B	Inhibition of rat recombinant geranylgeranyltransferase type I expressed in Escherichia coli assessed as reduction in geranylgeranylation of K-Ras4B incubated for 30 mins in presence of [3H]GGPP by scintillation counting assay	Rattus norvegicus	13	ALA4421722	assay format	Patent Bioactivity Data
11.	ALA4421916	B	Inhibition of rat recombinant geranylgeranyltransferase type I expressed in Escherichia coli assessed as reduction in geranylgeranylation of RhoA incubated for 30 mins in presence of [3H]GGPP by scintillation counting assay relative to control	Rattus norvegicus	87	ALA4421722	assay format	Patent Bioactivity Data
12.	ALA4421946	B	Inhibition of FTase in HEK293 cells assessed as reduction in H-ras farnesylation at 5 uM incubated for 48 hrs by SDS-PAGE and immunoblot analysis	Homo sapiens	1	ALA4421722	cell-based format	Patent Bioactivity Data
13.	ALA5150202	F	Antitumor activity against mouse NIH3T3 cells transfected with KRAS4B xenografted nude mouse assessed as inhibition of tumor growth at 35 mg/kg, ip administered in the presence of FTI-276 relative to control	Mus musculus	1	ALA5149962	organism-based format	Scientific Literature
14.	ALA5150204	F	Antitumor activity against mouse NIH3T3 cells transfected with H-Ras CVLS xenografted nude mouse assessed as inhibition of tumor growth at 70 mg/kg, ip administered once daily relative to control	Mus musculus	1	ALA5149962	organism-based format	Scientific Literature
15.	ALA5150206	F	Antitumor activity against human Calu-1 cells transfected with KRAS mutant xenografted nude mouse assessed as inhibition of tumor growth at 70 mg/kg, ip administrated once daily measure for 40 to 80 days relative to control	Homo sapiens	1	ALA5149962	organism-based format	Scientific Literature